The Medos ventricular assist device system

Thuaudet, S.
July 2000
Perfusion;Jul2000, Vol. 15 Issue 4, p337
Academic Journal
Deals with the Medos ventricular cardiac assist system. Details of its design; Clinical results of its testing.


Related Articles

  • European Society Of Cardiology. Purcell, Henry // Current Medical Literature: Interventional Cardiology Monitor;2004, Vol. 11 Issue 4, p90 

    Presents a report from the European Society of Cardiology meeting held August 28 to September 1, 2004 in Munich, Germany. Clinical trial called Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Senior with Heart Failure (SENIORS); Results from European Trial on...

  • Antibiotic Tested As Heart Treatment.  // Executive Health's Good Health Report;Feb99, Vol. 35 Issue 5, p3/5 

    Discloses that a clinical trial is set to begin in the United States to determine whether antibiotics are effective in the treatment of heart disease. Growing evidence suggesting a link between Chlamydia pneumoniae and heart disease; Aim to determine the role of the bacteria in the cause of...

  • What's New About Old Drugs. Linnebur, Sunny A. // Journal of Gerontological Nursing;Jan2004, Vol. 30 Issue 1, p4 

    Every month new clinical trials are published that provide relevant insight into medical care. Health care professionals are expected to review the results of these trials to update their knowledge and clinical practice. Although it is impossible to review every clinical trial, it is important...

  • Clopidogrel for Percutaneous Coronary Revascularization: Time for More Pretreatment, Retreatment, or Both? Moliterno, David J.; Steinhubl, Steven R. // JAMA: Journal of the American Medical Association;9/14/2005, Vol. 294 Issue 10, p1271 

    Presents an editorial regarding the treatment of ischemic heart disease for patients with acute coronary syndrome and for those undergoing percutaneous coronary intervention. Description of a study conducted by the Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial...

  • A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunction. Singh, Raveen; Choudhury, Minati; Kapoor, Poonam Malhotra; Kiran, Usha // Annals of Cardiac Anaesthesia;Sep2010, Vol. 13 Issue 3, p217 

    The deleterious effects of anesthetic agents in patients suffering from coronary artery disease are well known. The risk increases when a patient has compromised ventricular function. There is a paucity of literature regarding the choice of the suitable agent to avoid deleterious effects in such...

  • Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory Angina. Allen, Keith B.; Dowling, Robert D.; Fudge, Tommy L.; Schoettle, G. Phillip; Selinger, Samuel L.; Gangahar, Deepak M.; Angell, William W.; Petracek, Michael R.; Shaar, Carl J.; O'Neill, William W. // New England Journal of Medicine;09/30/99, Vol. 341 Issue 14, p1029 

    Background: Transmyocardial revascularization involves the creation of channels in the myocardium with a laser to relieve angina. We compared the safety and efficacy of transmyocardial revascularization performed with a holmium laser with those of medical therapy in patients with refractory...

  • Coronary Artery Disease (CAD) and Chinese Medicine. Flaws, Bob // Townsend Letter for Doctors & Patients;Aug/Sep2004, Issue 253/254, p42 

    Reports on the use of Chinese medicine to treat coronary artery disease in the U.S. Clinical trials of patients treated primarily employing the method of quickening blood and transforming stasis; Absence of recurrence of the angina or the cardiac arrhythmia; Signs and symptoms of phlegm obstruction.

  • Long term fenofibrate did not reduce major coronary events but may reduce total CVD events in type 2 diabetes. Keech, A. // Evidence Based Medicine;Jun2006, Vol. 11 Issue 3, p86 

    The article presents a research that examines the effect of long term fenofibrate therapy on coronary heart disease events in patients with type 2 diabetes mellitus. In this study, patients aged 50 to 75 years who diagnosed of type 2 diabetes with no clear indication for lipid modifying therapy...

  • Osiris' IV Adult Stem Cells Show Good Data.  // Bioworld Week;4/2/2007, Vol. 15 Issue 14, p3 

    The article reports that Baltimore-based Osiris Therapeutics Inc. has unfolded positive clinical data on its adult stem cell product Provacel in heart attack patients. As reported at the American College of Cardiology meeting in New Orleans, the findings revealed that patients receiving the...

  • Treatment Approaches.  // Current Medical Literature: Cardiology;2007, Vol. 26 Issue 3, p80 

    The article discusses research related to approaches in medical treatment. It includes "The Final 10-Year Follow-Up Results From the BARI Randomized Trial," by BARI Investigators, "Optical Medical Therapy With or Without PCI for Stable Coronary Disease," by W. E. Boden, R. A. O'Rourke and K. K....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics